Ledger.Open graph →
SEC Form D · filed July 16, 2018

TheraPten Biosciences Inc

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Nicholas Bearsted · New York, NYExec · DirectorRobert Waley-Cohen · New York, NYDirectorKyriakoulis Paganis · Anavyssos, J3DirectorMarc C. Pollack · Atlanta, GAExec · DirectorSteven Shores · Atlanta, GADirectorHarvey Lach · Kelowna, British Columbia, CanadaExec · DirectorKyriakoulis Paganis · Anavyssos, J3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗